Troponin I Level and Mortality in Acute Abdominal Surgery

July 2, 2023 updated by: Charlotte Tiffanie Bendtz Kanstrup, Nordsjaellands Hospital

Association Between Troponin I Levels and Mortality Among Patients Undergoing Acute High-risk Abdominal Surgery - a Cohort Study

The goal of this prospective cohort study is to estimate the incidence of myocardial injury after non-cardiac surgery (MINS) in patients undergoing acute high-risk abdominal surgery.

MINS is defined as at least one increased single measurement of plasma troponin I (TnI). TnI-dynamic is defined as either two succeeding measurements of TnI > 59 ng/l with an increase/fall of more than 20%, or by one measurements of TnI > 59 ng/l with a succeeding measurement of TnI < 59 ng/l and a decrease of more than 50%.

Participants will have plasma TnI measured 6-12 hours postoperatively and on each of the following four postoperative days. Follow-up will be minimum one year after surgery.

The aim of the study is to determine:

  • The incidence of MINS within the first four postoperative days
  • The incidence of dynamic TnI changes
  • The association between MINS and dynamic TnI changes respectively and all-course short-term mortality

Study Overview

Detailed Description

Gastrointestinal tract perforation, bowel ischemia and bowel obstruction are considered acute high-risk abdominal disorders, often requiring emergency surgery. Myocardial injury after non-cardiac surgery (MINS) is a frequent but often unrecognized postoperative complication. MINS is associated with an increased risk of other cardiac complications and 30-day mortality. However, the literature on MINS is mainly regarding patients undergoing a wide range of elective or acute surgical procedures, and we do not know if the dynamic TnI-criteria used for acute myocardial injury has any association with mortality in patients with MINS.

This study aims to estimate the incidence of MINS in patients undergoing AHA surgery, and the association between the short-term mortality and MINS defined as a single increased measurement of TnI and as TnI dynamics respectively.

Study Type

Observational

Enrollment (Actual)

341

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hillerød, Denmark, 3400
        • Copenhagen University Hospital - North Zealand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients undergoing surgery for gastrointestinal perforation, obstruction due to volvulus, tumour, strangulated hernia or adhesions, mesenterial ischemia or necrosis, or anastomotic leakage after gastrointestinal surgery.

Description

Inclusion Criteria:

  • 18 years or older
  • Patients undergoing acute high-risk abdominal surgery

Exclusion Criteria:

  • Patients with microscopic perforations in colonic diverticulitis managed with laparoscopic lavage or drainage
  • If further treatment postoperatively was assessed as futile and terminated immediately after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with MINS
Troponin I level equal to or above 59 ng/L
Measurements of plasma Troponin I 6-12 hours and on the first four postoperative days after surgery.
Patients without MINS
Troponin I level under 59 ng/L
Measurements of plasma Troponin I 6-12 hours and on the first four postoperative days after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of MINS within the first four postoperative days
Time Frame: The first four postoperative days
Postoperative troponin I level equal to or above 59 ng/L
The first four postoperative days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of dynamic plasma Troponin I changes
Time Frame: The first four postoperative days
Patients with postoperative troponin I level equal to or above 59 ng/L and a change of +20%
The first four postoperative days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The association between MINS and all-course mortality within 30 days, 90 days, and 1 year
Time Frame: 30-day, 90-day and 1-year
MINS defined as troponin I equal to or above 59 ng/L and mortality as yes/no
30-day, 90-day and 1-year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Claus A Bertelsen, Nordsjaellands Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Actual)

February 28, 2021

Study Completion (Actual)

February 28, 2022

Study Registration Dates

First Submitted

June 20, 2023

First Submitted That Met QC Criteria

July 2, 2023

First Posted (Actual)

July 6, 2023

Study Record Updates

Last Update Posted (Actual)

July 6, 2023

Last Update Submitted That Met QC Criteria

July 2, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdomen, Acute

Clinical Trials on Troponin I

Subscribe